Evidence map›Paper›PMID 40105394›Full record

ArticleCancer medicine2025

Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication.

Nicholas Brian Shannon, Narayanan Gopalakrishna Lyer, Melvin Lee Kiang Chua

Abstract read
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicholas Brian ShannonDivision of Surgery and Surgical Oncology, Department of Head and Neck Surgery, National Cancer Centre Singapore, Singapore.ORCID https://orcid.org/0000-0001-8742-8285
Narayanan Gopalakrishna LyerDivision of Surgery and Surgical Oncology, Department of Head and Neck Surgery, National Cancer Centre Singapore, Singapore.
Melvin Lee Kiang ChuaSingHealth Duke-NUS Oncology ACP, Singapore.ORCID https://orcid.org/0000-0002-1648-1473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNasopharyngeal carcinoma (NPC) typically presents as advanced disease due to the lack of significant symptoms in the early stages. Accurate prognostication is therefore challenging as current methods based on anatomical staging often lack the granularity to differentiate between patients with differing prognoses. This study investigates the potential of radiomics to improve the prediction of locoregional recurrence (LRR) and overall survival in patients with NPC.

methodsRadiomic features were extracted from radiotherapy planning CT scans for 294 NPC patients divided into training (n = 147) and validation (n = 147) sets. A feature selection step utilising feature clustering and mutual information classifier to select six key radiomic features was employed to reduce redundancy and improve interpretability. Models were trained using clinical data, radiomic features, and these in combination to predict 2-year LRR, with performance assessed on the left-out independent validation set.

resultsCombining radiomic features with clinical data resulted in the best performance for predicting 2-year LRR (Area Under the Curve, AUC 0.76) compared to prediction using clinical or radiomic features alone (mean AUC 0.56 and 0.57, respectively). Risk stratification based on the combined model was significant for LRR-free survival and overall survival (p < 0.01). Key radiomic features included tumour size, intensity distribution, overall textural patterns, and distribution of fine and coarse textured regions. DISCUSSION: Radiomics holds promise for improving NPC risk stratification, potentially allowing for personalised treatment strategies. The most important radiomics feature, maximum 2D diameter, suggests a need to reconsider tumour size as a prognostic criterion despite its current exclusion from TNM staging. Larger prospective studies are needed to validate these findings.

Indexed as

Artificial IntelligenceNasopharyngeal CarcinomaNasopharyngeal NeoplasmsNeoplasm Recurrence, LocalAdultAgedFemaleHumansMaleMiddle AgedNeoplasm StagingPrognosisRadiomicsRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedYoung Adultlocoregional recurrencemachine learningnasopharyngeal carcinomaradiomicsrisk stratification

Identifiers

PMID40105394
PMCPMC11921138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.